PUBLISHER: Grand View Research | PRODUCT CODE: 1751262
PUBLISHER: Grand View Research | PRODUCT CODE: 1751262
The global wound sealants market size was valued at USD 552.13 million in 2024 and is expected to expand at a CAGR of 5.63% from 2025 to 2030. The market's growth is attributed to the rising global volume of surgical procedures, fueled by an aging population and the increasing prevalence of chronic conditions such as diabetes and cardiovascular diseases.
The growing demand for minimally invasive surgeries, which require efficient and reliable wound closure methods, further boosts the adoption of sealants. In addition, advancements in biomaterials and synthetic formulations are enhancing wound sealants' effectiveness, safety, and usability, making them a preferred choice in traditional and modern surgical practices.
The rising prevalence of chronic wounds, such as diabetic foot ulcers and pressure ulcers, is anticipated to propel the market growth in the coming years. According to the article published by MDPI, in March 2025, diabetic foot is one of the most serious and challenging complications of diabetes, closely linked to high rates of lower limb amputation, as well as increased illness and mortality. Each year, around 18.6 million people globally are affected by diabetic foot ulcers, which are the leading cause of approximately 80% of diabetes-related lower limb amputations. It is estimated that up to 25% of individuals with diabetes are at risk of developing diabetic foot, and between 19% and 34% may experience foot ulcers at some point in their lifetime. Moreover, according to a study published by the American Medical Association in November 2023, around 33.33% of individuals with diabetes develop a foot ulcer during their lifetime. Diabetic foot ulcers impact about 1.6 million individuals in the U.S. each year. These factors are expected to drive the demand for wound sealants over the forecast period.
The growing number of surgical procedures, including cosmetic, orthopedic, and gynecologic, is anticipated to boost the market growth in the coming years. Wound sealants are widely used in various surgical procedures.
Ongoing innovation in sealant technology, with the development of improved biomaterials, delivery methods, and functionalities, is expanding its applications and driving market growth. For instance, in November 2023, Ethicon, a Johnson & Johnson MedTech company, announced the approval of ETHIZIA. This adjunctive hemostat solution has been clinically proven to achieve sustained hemostasis in challenging bleeding scenarios. Utilizing unique synthetic polymer technology, the ETHIZIA Hemostatic Sealing Patch is the first and only hemostatic matrix designed to provide equally effective hemostatic action on both sides. Furthermore, the trend toward minimally invasive and robotic surgeries has strengthened the need for sealants, as these procedures require precision and controlled closure without excessive tissue manipulation.
Moreover, increasing awareness among healthcare professionals and patients about the advantages of advanced wound care products, including wound sealants, is driving their adoption and supporting market growth. This awareness is being fueled by educational campaigns, clinical evidence showcasing their effectiveness, and a strong focus on achieving better patient outcomes.
Global Wound Sealants Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global wound sealants market report on the basis of sealants, wound type, end use, distribution channel, and region: